Biosyngen

Biosyngen company information, Employees & Contact Information

Explore related pages

Related company profiles:

Biosyngen is a cell therapy company focusing on unmet needs with technology targeting solid tumors and lymphoproliferative diseases. The company’s first-in-class products have entered into Phase I/II clinical trials for nasopharyngeal cancer (ODD and Fast-Track), lymphoproliferative disease and lung cancer. The company continues to enrich its pipeline with further IND submissions. Biosyngen drives its international strategy from the global headquarter in Singapore, with its clinical center situated in Guangzhou, China. Leverages on the public-private biopharma ecosystem for the better cause. Committed to giving cancer patients a better chance to survive, our pipeline is enriched, covering other major indications which are on track for regulatory registration. Biosyngen seeks breakthrough in collaborations, particularly in translational R&D and clinical development. The company has positioned GMP cell therapy manufacturing facilities in two locations - in Singapore and Guangzhou covering global needs. To quicken drug development from bench-to-bedside, a parallel effort in the form of the Translational Medicine Centre is set up. It is public-private-partnership connecting stakeholders in R&D, Clinical Development, Hospitals, Pharma, Enterprises and Venture Capital. Follow us on LinkedIn. For more information, visit our website at www.biosyngen.com

Company Details

Employees
23
Founded
-
Address
5 Tai Seng Avenue, #08-51,singapore
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Hougang, North East Community Development Council
Looking for a particular Biosyngen employee's phone or email?

Biosyngen Questions

News

FDA Accepts Atara Biotherapeutics’ Resubmission of BLA for Tabelecleucel - CGTLive®

FDA Accepts Atara Biotherapeutics’ Resubmission of BLA for Tabelecleucel CGTLive®

Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA - BioSpace

Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA BioSpace

Singapore-based Biosyngen receives 500 million yuan in investment - 美通社

Singapore-based Biosyngen receives 500 million yuan in investment 美通社

TCR-T Therapy Cleared for Lung, Gastric Cancer Trial - CGTLive®

TCR-T Therapy Cleared for Lung, Gastric Cancer Trial CGTLive®

Biosyngen partners with Singapore's A*STAR to advance autoimmune therapy - BioSpectrum Asia

Biosyngen partners with Singapore's A*STAR to advance autoimmune therapy BioSpectrum Asia

Biosyngen Announces FDA Fast Track Designation for BST02 in Treatment of Liver Cancer - ANTARA News

Biosyngen Announces FDA Fast Track Designation for BST02 in Treatment of Liver Cancer ANTARA News

FDA Clears Biosyngen’s CAR-T Therapy BRG01 for Pivotal Trial in EBV-Positive Nasopharyngeal Carcinoma - CGTLive®

FDA Clears Biosyngen’s CAR-T Therapy BRG01 for Pivotal Trial in EBV-Positive Nasopharyngeal Carcinoma CGTLive®

S'pore-based firm Biosyngen working on harnessing the immune system to kill cancer cells - The Straits Times

S'pore-based firm Biosyngen working on harnessing the immune system to kill cancer cells The Straits Times

Biosyngen Pte Ltd launched biological production base for commercialization of immune cell therapeutics in China - 美通社

Biosyngen Pte Ltd launched biological production base for commercialization of immune cell therapeutics in China 美通社

Singapore-based firm Biosyngen opens new manufacturing facility, set to hire 200 people - The Straits Times

Singapore-based firm Biosyngen opens new manufacturing facility, set to hire 200 people The Straits Times

Biosyngen’s CAR-T Therapy BRG01 Cleared for Pivotal Trial in EBV-Positive Nasopharyngeal Carcinoma in China - CGTLive®

Biosyngen’s CAR-T Therapy BRG01 Cleared for Pivotal Trial in EBV-Positive Nasopharyngeal Carcinoma in China CGTLive®

Biosyngen Gives Cell Therapy GMP Capabilities in Singapore A Boost - 美通社

Biosyngen Gives Cell Therapy GMP Capabilities in Singapore A Boost 美通社

Top Biosyngen Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant